Research Article
Immediate Radical Cystectomy for Massive Bleeding of Bladder Cancer
Table 3
Clinical and pathological data.
| | Grade | | | High | 12/12 (100%) | | Concomitant CIS | 2/12 (16%) | | cTNM | | | T3a | 4/12 (33%) | | T3b | 6/12 (50%) | | T4 | 2/12 (16%) | | N0 | 6/12 (50%) | | N1 | 2/12 (16%) | | N2 | 2/12 (16%) | | N3 | 2/12 (16%) | | M0 | 8/12 (67%) | | M1 | 4/12 (33%) | | pTNM | | | T2b | 2/12 (16%) | | T3a | 4/12 (33%) | | T4 | 6/12 (50%) | | N0 | 4/12 (33%) | | N1 | 4/12 (33%) | | N2 | 2/12 (16%) | | N3 | 2/12 (16%) | | M0 | 8/12 (67%) | | Mx | 4/12 (33%) | | Mean lymph node removed | 17 (12–21) | | Urinary diversion | | | UCS | 4/12 (33%) | | IC | 4/12 (33%) | | Orthotopic ileal neobladder | 2/12 (16%) | | Overall PSM | 4/12 (33%) | | Positive STSM | 1/12 (8%) | | Concomitant prostate cancer | 4/12 |
|
|
UCS: ureterocutaneostomy; IC: ileal conduit; PSM: positive surgical margins; STSM: soft tissue surgical margin.
|
